Valuation Cipher Pharmaceuticals Inc.

Stocks

Market Closed - Toronto S.E. 16:00:00 2026-10-30 EDT			5-day change	1st Jan Change
13.05 ^CAD	-3.33%		-4.40%	-13.35%

09-21	Cipher Pharmaceuticals Inc. Announces Appointment of Rajiv De Silva to Board of Directors, Effective September 21, 2026	CI
09-01	Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	46.45	96.48	133.1	366.4	382.2	343.1	-	-
Change	-	107.72%	37.94%	175.35%	4.29%	-10.22%	-	-
Enterprise Value (EV)	46.45	96.48	133.1	366.4	382.2	343.1	343.1	343.1
Change	-	107.72%	37.94%	175.35%	4.29%	-10.22%	0%	0%
P/E	4.83x	2.71x	5.12x	21.8x	10.5x	11.6x	10.8x	10.4x
PBR	0.93x	1.11x	1.29x	2.47x	2.23x	1.62x	1.39x	1.21x
PEG	-	0x	-0.2x	-0.6x	0x	-0.5x	1.35x	2.95x
Capitalization / Revenue	1.67x	3.39x	4.65x	7.68x	5.56x	4.84x	4.22x	4.01x
EV / Revenue	0x	0x	0x	0x	0x	4.84x	4.22x	4.01x
EV / EBITDA	0x	0x	0x	0x	0x	8.32x	7.08x	6.54x
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	0x	9.41x	-	-
FCF Yield	-	-	-	-	10.6%	10.6%	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3666	1.417	1.081	0.658	1.43	1.124	1.214	1.256
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	27.74	28.43	28.6	47.72	68.73	70.85	81.35	85.63
EBITDA ¹	17.59	17.11	17.19	22.43	38.22	41.25	48.49	52.44
EBIT	-	-	-	-	-	-	-	-
Net income ¹	9.807	36.63	27.55	16.51	37.23	27.7	31.76	32.77
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	1.77	3.84	5.54	14.32	15.06	13.05	13.05	13.05
Nbr of stocks (in thousands)	26,241	25,124	24,022	25,590	25,377	25,415	-	-
Announcement Date	3/17/22	3/16/23	3/14/24	3/18/25	3/12/26	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CIPHER PHARMACEUTICALS INC.	12.02x	-	-	-	245M
ELI LILLY AND COMPANY	40.35x	13.85x	30.26x	0.5%	1,224B
JOHNSON & JOHNSON	40.28x	6.76x	19.02x	1.94%	662B
ABBVIE INC.	38.08x	8.51x	17.61x	2.36%	514B
ROCHE HOLDING AG	21.65x	5.25x	13.07x	2.49%	388B
MERCK & CO., INC.	106.67x	5.95x	25.48x	2.33%	361B
NOVARTIS AG	22.86x	5.89x	14.22x	2.75%	302B
ASTRAZENECA PLC	22.82x	4.6x	13.15x	1.92%	271B
AMGEN INC.	29.23x	7.45x	13.34x	2.19%	249B
GILEAD SCIENCES, INC.	-47.64x	7.37x	28.55x	1.99%	205B
Average	28.63x	7.29x	19.41x	2.05%	417.71B
Weighted average by Cap.	36.66x	8.71x	21.55x	1.73%